Clinical Trial VICCHEM1137
MicroRNAs in Myelodysplastic Syndrome
- Protocol No. VICCHEM1137
- Open Date: 07/22/2011
- Staging: NA
- Age Group: Adults
- Scope: National
- Objective: Determine the contribution of hypermethylation in the dysregulation of miRNA expression in MDS.
- Disease Sites:
- Therapies: Correlative
- Drugs: None Specified
- Participating Institutions: Boston Baskin Cancer Group (UTCI); Thomas Jefferson University Hospital; Jackson-Madison County Hospital; Roswell Park Cancer Institute; The Jones Clinic; Vanderbilt University
- Secondary Protocol No: Not Specified
Not provided. Please call for more information.